185
person
Erik Roberson, MD, PhD
Erik Roberson, MD, PhD, is a physician-scientist with a focus on age-related neurodegenerative di
seases.
+ Read More
person
Bruce Miller, MD
Bruce Miller, MD, holds the A.W.
person
Stephen J. Haggarty, PhD
Stephen J.
person
David Siemer
David Siemer is the Co-Founder and CEO of Wave Digital Assets as well as the founder of Wavemaker
Partners and Wavemaker Genesis. Wavemaker includes seven funds with an AUM of $300m in the US and Southeast Asia which have all posted top-decile returns.
+ Read More
person
Ivan Soto-Wright
Soto-Wright is a leading financial technology entrepreneur and investor. Throughout his career, h
e has advocated for building systems and developing technologies that increase financial freedom.
+ Read More
person
Megan B. Miller, PhD
Megan B. Miller, PhD, is a socially minded neuroscientist with a passion for brain health advocac
y and strategic planning.
+ Read More
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Corporate Philanthropy: Emerging Strategies for Lasting Impact
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations ha
ve placed new pressures on the corporate sector.
+ Read More